ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978

DCPC BSC Committee Okay Three Concepts

September 13, 1985

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

April 28, 1978

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010